High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia. Issue 5 (11th February 2022) - Pourhassan, Hoda; Yang, Dongyun; Afkhami, Michelle; Pillai, Raju; Ball, Brian; Al Malki, Monzr; Salhotra, Amandeep; Ali, Haris; Artz, Andrew; Curtin, Peter; Armenian, Saro; Stein, Anthony; et al.